| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000272192.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.035356127 |
Resistant |
| ENSG00000272192.1 |
Ponatinib |
Colon adenocarcinoma |
0.028691369 |
Resistant |
| ENSG00000272192.1 |
Ponatinib |
Brain lower grade glioma |
0.029263082 |
Resistant |
